Bicycle Therapeutics Plc (BCYC)
4.94
-0.03
(-0.60%)
USD |
NASDAQ |
Apr 10, 16:00
4.945
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics EPS Diluted (Quarterly) : -0.2901 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0461 |
| Autolus Therapeutics Plc | -0.3389 |
| NuCana Plc | -0.7979 |
| DBV Technologies SA | -1.170 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.12M |
| Revenue (Quarterly) | 47.89M |
| Total Expenses (Quarterly) | 68.01M |
| Enterprise Value | -266.78M |
| Gross Profit Margin (Quarterly) | 97.21% |
| Profit Margin (Quarterly) | -42.03% |
| Earnings Yield | -64.23% |
| Normalized Earnings Yield | -64.23 |